☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Extensive-Stage Small Cell
Roche's Tecentriq (atezolizumab) + Chemotherapy (carboplatin and etoposide) Receive FDA's Approval for Extensive-Stage Small Cell...
March 19, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.